Clinical trial
EGFR Pathway Mutations in Lung Cancer Patient Tumors and Blood
NCT00899405 is registered in ClinicalTrials.gov with University of California, Davis as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- EGFR Pathway Mutations in Lung Cancer Patient Tumors and Blood
- Lead sponsor
- University of California, Davis
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- May 19, 2004
- Completion date
- May 31, 2034
- Enrollment
- 800 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
lung cancer